Survival of blood donors and their spouses with HIV-1 subtype e (CRF01 A_E) infection in northern Thailand, 1992-2007

AIDS

Volumn 21, Issue SUPPL. 6, 2007, Pages

  Nelson, Kenrad E ^a   Costello, Caroline ^b,d   Suriyanon, Vinai ^c   Sennun, Supaluk ^c   Duerr, Ann ^b,e  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c CHIANG MAI UNIVERSITY   (Thailand)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

HIV natural history; Low middle income countries; Survival; Thailand

Indexed keywords

ADOLESCENT; ADULT; BLOOD DONOR; CONFERENCE PAPER; DEATH CERTIFICATE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INCIDENCE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROCONVERSION; SPOUSE; SURVIVAL; THAILAND;

EID: 36349021915     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000299410.37152.17     Document Type: Conference Paper

References (33)

1. UNAIDS. AIDS epidemic update, December 2006. Available at: http://data.unaids.org/pub/EpiReport/2006/2006_EpiUpdate_en.pdf. Accessed: September 2007.
2. Crampin AC, Floyd S, Glynn JR, Sibande F, Mulawa D, Nyondo A, et al. Long-term follow-up of HIV-positive and HIV-negative individuals in rural Malawi. AIDS 2002; 16:1545-1550.
3. Glynn J, Sonnenberg P, Nelson G, Bester A, Stuart S, Murray J. Survival form HIV-1 seroconversion in Southern Africa: a retrospective cohort study in nearly 2000 gold-miners over 10 years of follow-up. AIDS 2007; 21:625-632.
4. Vasan S, Renijifo B, Hertzmark E, Chaplin B, Msamanga G, Essex M, et al. Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype. Clin Infect Dis 2006; 42:843-852.
5. Morgan D, Whitworth JAG. The natural history of HIV-1 infection in Africa. Nat Med 2001; 7:143-145.
6. Morgan D, Mahe L, Mayanja B, Okongo JM, Lubega R, Whitworth JAG. HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries? AIDS 2002; 16:597-603.
7. Todd J, Glynn JR, Marston M, Lutalo T, Biraro S, Mwita W, et al. Time from HIV seroconversion to death: a collaborative analysis of eight studies in six low and middle-income countries before highly active antiretroviral therapy. AIDS 2007; 21 (Suppl. 6):S55-S63.
8. Jaffar S, Grant AD, Whitworth J, Smith PG, Whittle H. The natural history of HIV-1 and HIV-2 infections in adults in Africa: a literature review. Bull WHO 2004; 82:462-469.
9. Anzalo O, Nagelkerke N, Bwayo J, Holton D, Moses S, Ngugi EN, et al. Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection. J Infect Dis 1995; 171:686-689.
10. Morgan D, Maude GH, Malamba SS, Okongo MJ, Wagner HU, Mulder DW, et al. HIV-1 disease progression and AIDSdefining disorders in rural Uganda. Lancet 1997; 350:245-250.
11. French N, Mujugira A, Nakiyingi J, Mulder D, Janoff EN, Gilks CF. Immunologic and clinical stages in HIV-1 infected Uganda adults are comparable and provide no evidence of rapid progression but poor survival with advanced disease. J Acquir Immune Defic Syndr 1999; 22:509-516.
12. Kanki P, Hanel D, Sankale JL, Hsieh C, Thior I, Barin F, et al. Human immundeficiency virus type 1 subtypes differ in disease progression. J Infect Dis 1999; 179:68-73.
13. Senkaali D, Muwonge R, Morgan D, Yirrell D, Whitworth J, Kaleebu P. The relationship between HIV type-1 disease progression and V3 serotype in a rural Ugandan cohort. AIDS Res Human Retroviruses 2004; 20:932-937.
14. Baeten JM, Chohan B, Lavreys C, Chohan V, McClelland RS, Certain L, et al. HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. J Infect Dis 2007; 195:1177-1180.
15. Kiwanuka N, Laeyendecker O, Arroyo M, et al. Different rates of disease progression by subtype in Rakai, Uganda. In: 14th Conference on Retroviruses and Opportunistic Infections. Los Angeles, CA, 25-28 February 2007 [Abstract 307].
16. Rangsin R, Chui J, Khamboonruang C, Sirisopana N, Eiumtrakul S, Brown AE, et al. The natural history of HIV-1 infection in young Thai men after seroconversion. J Acquir Immune Defic Syndr 2004; 36:622-629.
17. Costello C, Nelson KE, Suriyanon V, Sennun S, Tovanabutra S, Heilig CM, et al. HIV-1 subtype progression among northern Thai couples: traditional and non-traditional predictors of survival. Int J Epidemiol 2005; 24:579-584.
18. Kilmarx PH, Limpakarnjanarat K, Kaewkungwal J, Srismith R, Saisorn S, Uthaivoravit W, et al. Disease progression and surivial with human immunodeficiency virus type 1 subtype E infection among female sex workers in Thailand. J Infect Dis 2005; 18:1598-1606.
19. Nantachit N, Robison V, Wongthance A, Kamtorn N, Suriyanon V, Nelson KE. Temporal trends in the prevalence of HIV and other transfusion-transmissible infections among blood donors in Northern Thailand, 1990 through 2001. Transfusion 2003; 43:730-735.
20. Pau CP, Lee-Thomas S, Auwanit W, George JR, Qu CY, Parekh BS, et al. Highly specific V3 peptide enzyme immunoassay for serotyping HIV-1 specimens from Thailand. AIDS 1993; 7:337-340.
21. Subbarao S, Limpakarnjanarat K, Mastro TD, Bhumisawasdi J, Warachit P, Jayavasu C, et al. HIV type 1 in Thailand, 1994-1995: persistence of two subtypes with low genetic diversity. AIDS Res Hum Retroviruses 1998; 4:319-327.
22. Nagachinta T, Duerr A, Suriyanon V, Nantachit N, Rugpao S, Wanapirak C, et al. Risk factors for HIV-1 transmission from HIV-seropositive male blood donors to their regular female partners in northern Thailand. AIDS 1997; 11:1765-1772.
23. Collaborative Group on AIDS Incubation and HIV Survival Including the CASCADE EU Concerted Action. Time from HIV-1 sero-conversion to AIDS and death before the widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Lancet 2000; 355:1131-1137.
24. Rangsin R, Piyaraj P, Sirisanthana T, Sirisopana N, Short O, Nelson KE. The natural history of HIV-1 subtype E in young men in Thailand with up to 14 yeas of follow-up. AIDS 2007; 21 (Suppl. 6):S39-S46.
25. Hu D, Vanichseni S, Mastro TD, Raktham S, Young NL, Mock PA, et al. Viral load differences in early infection with two HIV-1 subtypes. AIDS 2001; 15:683-691.
26. Kunanasont C, Foy HM, Kreiss JK, Rerks-Ngarm S, Phanuphak P, Pau CP, et al. HIV-1 subtypes and male to female transmission in Thailand. Lancet 1995; 345:1078-1083.
27. Nelson KE, Rungruengthanakit K, Margolick J, Suriyanon V, Niyomthai S, de Boer MA, et al. High rates of subtype E human immunodeficiency virus type 1 transmission among heterosexual couples in northern Thailand: role of STDs and immune compromise. J Infect Dis 1991; 143:233-239.
28. Kaslow RA, Dovak T, Tang J. Influence of genetic variation on susceptibility to HIV type1 infection. J Infect Dis 2005; 191 (Suppl. 11):S63-S77.
29. Carrington M, O'Brien S. The influence of HLA genotype on AIDS. Annu Rev Med 2003; 54:535-551.
30. Cao K, Hollenbach J, Shi X, Shi W, Chopek M, Fernandez-Vina MA. Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations. Hum Immunol 2001; 62:1009-1030.
31. Chandanayingyong D, Stephens HA, Klaythong R, Sirikong M, Udee S, Longta P, et al. HLA-A, -B, -DRB1, -DQA1, and -DQB1 polymorphism in Thais. Hum Immunol 1997; 53:174-182.
32. Paris R, Bejrachandra S, Karnasuta C, Chandanayingyong D, Kunachiwa W, Leetrakool N, et al. HLA class I serotypes and cytotoxic T-lymphocyte responses among human immunodeficiency virus-1-uninfected Thai volunteers immunized with ALVAC-HIV in combination with monomeric gp120 or oligomeric gp160 protein boosting. Tissue Antigens 2004; 64:251-256.
33. Weniger BG, Limpakarnjanarat K, Unjchusak K, Thanprasertsuk S, Choopanya K, Vanichseni S, et al. The epidemiology of HIV infection and AIDS in Thailand. AIDS 1991; 5 (Suppl. 1.2):S71-S85. Published erratum appears in AIDS 1993; 7:147.